SCHEMBL13748014

SCHEMBL13748014

COC(=O)C(OC(=O)[C@@H]1CCCN1C(=O)OC(C)(C)C)C(=O)c1ccc(C)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.52
▸ NPSR1 Q6W5P4 1/20 0.52
▸ NPC1 O15118 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ KMT2A Q03164 4/20 0.46
▸ MEN1 O00255 3/20 0.46
▸ UCHL1 P09936 2/20 0.43
▸ EPHX2 P34913 1/20 0.42
▸ USP30 Q70CQ3 1/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ KLK7 P49862 1/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ HRH2 P25021 1/20 0.40
▸ HRH1 P35367 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ GLA P06280 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13747276 0.91 KMT2A (0.49) LMNANPSR1NPC1L3MBTL1KMT2A
SCHEMBL12159690 0.91 NPC1 (0.50) LMNANPSR1NPC1L3MBTL1KMT2A
SCHEMBL13747280 0.86 KLK7 (0.53) LMNANPSR1NPC1KMT2AMEN1
SCHEMBL22673801 0.84 MEN1 (0.53) LMNANPSR1NPC1L3MBTL1KMT2A
SCHEMBL692266 0.83 KMT2A (0.48) LMNANPSR1NPC1KMT2AMEN1
SCHEMBL692265 0.83 KMT2A (0.48) LMNANPSR1NPC1KMT2AMEN1
SCHEMBL22674061 0.81 MEN1 (0.50) LMNANPSR1NPC1KMT2AMEN1
SCHEMBL22674058 0.81 MEN1 (0.50) LMNANPSR1NPC1KMT2AMEN1
SCHEMBL22673848 0.81 MEN1 (0.49) LMNANPSR1NPC1KMT2AMEN1
SCHEMBL15848405 0.79 LMNA (0.53) LMNANPSR1NPC1L3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009102325-A1 IMIDAZOLYL BIPHENYL IMIDAZOLES AS HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-08-20 — — WO disclosed
WO-2009102318-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-08-20 — — WO disclosed
WO-2008021936-A2 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2008-02-21 — — WO disclosed
WO-2008021928-A2 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2008-02-21 — — WO disclosed
WO-2008021927-A2 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2008-02-21 — — WO disclosed
Send feedback